Results 221 to 230 of about 145,462 (345)

The Third Pillar of Precision Medicine — Precision Delivery

MedComm, Volume 6, Issue 5, May 2025.
For Precision Medicine to reach its full potential, a third pillar called Precision Delivery is starting to evolve to complement the existing two pillars of Precision Diagnosis and Precision Therapy. Precision Delivery will help ensure the right therapy for the right disease will be able to reach the right location at the right time .
Avnesh S. Thakor
wiley   +1 more source

Xanthatin induces apoptosis through ROS-mediated c-FLIP inhibition in human retinoblastoma cells. [PDF]

Front Med (Lausanne)
Gao X, Li Y, Xu H, Ni S, Pan H, Ma C, Zhao X, Zhang H.   +7 more
europepmc   +1 more source

Normal bone maturation in GH and somatomedin (SM) deficient children with pituitary irradiation for retinoblastoma [PDF]

, 1981
R Pomarède, P Czernichow, Joaquin U. Gonzales, C Prévôt, R Rappaport, J M Zucker   +5 more
openalex   +1 more source

Challenges and Opportunities of a Multi‐Institutional Treatment Guideline for Wilms Tumor in Low‐Middle‐Income Countries—A Report From the Asociación de Hemato‐Oncología Pediátrica de Centro América (AHOPCA)

Pediatric Blood &Cancer, Volume 72, Issue 5, May 2025.
ABSTRACT Since 2000, centers across Central America have shared treatment guidelines for Wilms tumor, using histology (anaplasia present or absent) and tumor stage to stratify patients into low‐, intermediate‐, and high‐risk groups. Weekly virtual tumor board meetings involving local and international experts were held to ensure consistent treatment ...
Patricia Valverde, Thelma Velasquez, Roberta Ortiz, Soad Linneth Fuentes‐Alabi, Armando Peña, José Fernando Gonzalez, Tito Luis Gutierrez, Luis Enrique Melendez, Enrique Tome, Magda Arreola, Maria Grazia Valsecchi, Valeria Colombo, Sandra Luna‐Fineman, Jessica Blanco‐Lopez, Monika L. Metzger, Filippo Spreafico   +15 more
wiley   +1 more source

NEK2 Control of Esophageal Squamous Cell Carcinoma Growth Based on Circadian Oscillation

Cancer Science, Volume 116, Issue 5, Page 1282-1294, May 2025.
Our findings position NEK2 as a time‐dependent oncogene and a potential biomarker in ESCC, highlighting its role in both tumorigenesis and the circadian rhythm. ABSTRACT Esophageal squamous cell carcinoma (ESCC) is a globally prevalent malignancy known for its aggressive nature and unfavorable outcomes.
Boning Zeng, Chao Sun, Nan Li, Qiuling Chen, Manni Rao, Kai Li, Xiaodi Liu, Shouxia Xie, Jiwu Cheng, Shaoxiang Wang, Xiao Wang   +10 more
wiley   +1 more source

Author's Reply: Retinoblastoma [PDF]

, 1982
David H. Abramson
openalex   +1 more source

Tumor heterogeneity in retinoblastoma: a literature review. [PDF]

Cancer Metastasis Rev
Pallavi R, Soni BL, Jha GK, Sanyal S, Fatima A, Kaliki S.   +5 more
europepmc   +1 more source

Frequency of Retinoblastoma at Lady Reading Hospital, Peshawar, Pakistan

, 1970
Zafar Iqbal, Tariq Muhammad Saeed
openalex   +2 more sources

Frequency and Implications of High‐Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort

Clinical and Translational Science, Volume 18, Issue 5, May 2025.
ABSTRACT Pharmacogenomics remains underutilized in pediatric oncology, despite the existence of evidence‐based guidelines. Implementation of pharmacogenomics‐informed prescribing could improve medication safety and efficacy in pediatric oncology patients, who are at high risk of adverse drug reactions.
Claire Moore, Andreas Halman, Tayla Stenta, Dhrita Khatri, Elizabeth Williams, Roxanne Dyas, Julian Stolper, David A. Elliott, Rachel Conyers   +8 more
wiley   +1 more source

Retinocytoma: understanding pathogenesis, diagnosis, and treatment approaches. [PDF]

Int J Retina Vitreous
Al-Hussaini M, Sharie SA, Sultan H, Mohammad M, Yousef YA.   +4 more
europepmc   +1 more source